Matthew Ros

Director/Board Member at COGENT BIOSCIENCES, INC.

Net worth: 216 500 $ as of 2026-05-30

59 year

96 connections

Health Technology

Health Services

Consumer Services

Profile

Matthew E.
Ros is currently an Independent Director at Cogent Biosciences, Inc. since 2019.
Former roles include Chief Executive Officer & Director at Fore Biotherapeutics, Inc. from 2022 to 2023; Senior Director at Bristol Myers Squibb Co. from 1990 to 2007; Senior Vice President-Commercial Operations at ARIAD Pharmaceuticals, Inc. from 2009 to 2010; Vice President & Head-Franchise at Genzyme Corp.
from 2012 to 2014; Associate Vice President at Sanofi from 2010 to 2012; COO, VP & Global Head-Oncology Business Unit at Sanofi from 2014 to 2016; Chief Financial Officer at Epizyme, Inc. in 2021; Trustee at Cancer Care, Inc.; and Chief Operating Officer at Verastem, Inc. in 2025.
Education includes an undergraduate degree from The State University of New York, conferred in 1988.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VERASTEM, INC. 0.08%	2025-03-31	50,000 ( 0.08% )	216 500 $	2026-05-30
COGENT BIOSCIENCES, INC. -.--%	2026-04-12	0 ( -.--% )	- $	2026-05-30

Matthew Ros active positions

Companies	Position	Start
COGENT BIOSCIENCES, INC.	Director/Board Member	2019-07-25

All active positions of Matthew Ros

Former positions of Matthew Ros

Companies	Position	End
VERASTEM, INC.	Chief Operating Officer	2025-12-14
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Chief Executive Officer	2023-07-31
EPIZYME, INC.	Director of Finance/CFO	2021-09-30
SANOFI	Chief Operating Officer	2016-04-30
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	2014-11-30

See the detail of Matthew Ros's experience

Training of Matthew Ros

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Ros's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Cogent Biosciences, Inc. Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer	Health Technology
Cancer Care, Inc. Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Health Services
The State University of New York The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers	Health Technology
Verastem, Inc. Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs	Health Technology
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Health Technology